Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Update

Clearmind Medicine Inc. (NASDAQ:CMND) saw a significant increase in short interest in January. As of January 15th, there was short interest totalling 620,700 shares, an increase of 453.7% from the December 31st total of 112,100 shares. Based on an average trading volume of 1,140,000 shares, the short-interest ratio is currently 0.5 days. Currently, 21.0% of the shares of the company are sold short.

Clearmind Medicine Price Performance

Shares of Clearmind Medicine stock opened at $1.37 on Wednesday. The business’s fifty day simple moving average is $1.41 and its 200 day simple moving average is $1.40. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.01. Clearmind Medicine has a 12 month low of $0.95 and a 12 month high of $2.30.

Clearmind Medicine (NASDAQ:CMND) last released its earnings results on Wednesday, January 22nd. The company reported ($0.11) EPS for the quarter.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.